Free Trial

M&T Bank Corp Cuts Position in CVS Health Corporation (NYSE:CVS)

CVS Health logo with Medical background

M&T Bank Corp lessened its holdings in CVS Health Corporation (NYSE:CVS - Free Report) by 8.6% in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 181,289 shares of the pharmacy operator's stock after selling 17,012 shares during the period. M&T Bank Corp's holdings in CVS Health were worth $12,282,000 at the end of the most recent quarter.

Several other hedge funds have also recently added to or reduced their stakes in CVS. Hopwood Financial Services Inc. bought a new stake in shares of CVS Health during the fourth quarter valued at approximately $29,000. McIlrath & Eck LLC raised its position in CVS Health by 32.6% in the 4th quarter. McIlrath & Eck LLC now owns 707 shares of the pharmacy operator's stock valued at $32,000 after buying an additional 174 shares during the last quarter. Park Square Financial Group LLC acquired a new position in CVS Health during the fourth quarter worth $43,000. PARK CIRCLE Co grew its holdings in shares of CVS Health by 42.9% in the 4th quarter. PARK CIRCLE Co now owns 1,000 shares of the pharmacy operator's stock valued at $45,000 after acquiring an additional 300 shares in the last quarter. Finally, Strategic Investment Solutions Inc. IL raised its stake in shares of CVS Health by 77.2% during the 4th quarter. Strategic Investment Solutions Inc. IL now owns 1,024 shares of the pharmacy operator's stock worth $46,000 after purchasing an additional 446 shares in the last quarter. Institutional investors and hedge funds own 80.66% of the company's stock.

Insider Transactions at CVS Health

In related news, Director Guy P. Sansone bought 1,570 shares of the business's stock in a transaction that occurred on Thursday, June 5th. The stock was bought at an average cost of $63.70 per share, for a total transaction of $100,009.00. Following the completion of the transaction, the director owned 12,007 shares of the company's stock, valued at approximately $764,845.90. The trade was a 15.04% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Company insiders own 1.22% of the company's stock.

Analysts Set New Price Targets

A number of equities analysts recently commented on CVS shares. Wall Street Zen upgraded CVS Health from a "hold" rating to a "buy" rating in a report on Friday, May 9th. Piper Sandler upped their price target on shares of CVS Health from $72.00 to $74.00 and gave the stock an "overweight" rating in a report on Friday, March 21st. Mizuho boosted their price objective on shares of CVS Health from $70.00 to $76.00 and gave the stock an "outperform" rating in a research note on Wednesday, April 9th. Royal Bank Of Canada upped their price target on shares of CVS Health from $74.00 to $81.00 and gave the company an "outperform" rating in a research report on Monday, May 5th. Finally, Jefferies Financial Group increased their price objective on shares of CVS Health from $74.00 to $80.00 and gave the stock a "buy" rating in a research report on Monday, June 30th. Two investment analysts have rated the stock with a hold rating, eighteen have issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, CVS Health has a consensus rating of "Moderate Buy" and an average price target of $75.06.

View Our Latest Research Report on CVS Health

CVS Health Stock Performance

CVS stock traded down $1.08 during midday trading on Thursday, reaching $65.58. 6,326,674 shares of the company's stock traded hands, compared to its average volume of 10,798,099. The company has a 50-day moving average price of $65.18 and a two-hundred day moving average price of $61.93. The company has a debt-to-equity ratio of 0.77, a quick ratio of 0.63 and a current ratio of 0.82. CVS Health Corporation has a 52 week low of $43.56 and a 52 week high of $72.51. The firm has a market capitalization of $82.96 billion, a PE ratio of 15.65, a price-to-earnings-growth ratio of 0.95 and a beta of 0.57.

CVS Health (NYSE:CVS - Get Free Report) last released its quarterly earnings results on Thursday, May 1st. The pharmacy operator reported $2.25 EPS for the quarter, beating analysts' consensus estimates of $1.62 by $0.63. The firm had revenue of $94.59 billion during the quarter, compared to analyst estimates of $93.07 billion. CVS Health had a net margin of 1.39% and a return on equity of 10.59%. The business's revenue for the quarter was up 7.0% on a year-over-year basis. During the same period in the previous year, the business earned $1.31 EPS. As a group, equities analysts anticipate that CVS Health Corporation will post 5.89 EPS for the current year.

CVS Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, August 1st. Investors of record on Tuesday, July 22nd will be given a $0.665 dividend. The ex-dividend date is Tuesday, July 22nd. This represents a $2.66 annualized dividend and a yield of 4.06%. CVS Health's dividend payout ratio (DPR) is presently 63.48%.

CVS Health Profile

(Free Report)

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

Recommended Stories

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Should You Invest $1,000 in CVS Health Right Now?

Before you consider CVS Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CVS Health wasn't on the list.

While CVS Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Don’t Miss These Top 3 Defense Stocks Set To Gain
Triple-Digit Gains: These 4 Nuclear Stocks Have Even More Upside Ahead
3 Made in America Stocks Under $20 You Need to See!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines